Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half ...

A limited amount of retail products containing benzoyl peroxide have been voluntarily recalled after testing for possible benzene contamination.

That could include probiotics, both topical and oral. Two recent reviews of studies investigating this possibility suggest ...

The Company claims the sponge powder exfoliates the skin, promotes collagen production, and opens closed comedones.

Valisure, an independent quality advocate, filed a citizen petition claiming to have detected elevated levels of benzene in ...

Dermata Therapeutics shares jumped more than 50% in early trading Thursday after the biotechnology company said its Xyngari once-weekly, topical product candidate for the treatment of ...

Dermata Therapeutics (DRMA) announced positive topline results from the company’s first pivotal Phase 3 trial of xyngari, a novel, once-weekly, ...

Is this growing wellness trend the holy grail of holistic health remedies, or is it a scam? I took a deep dive to find out.

Shares of Dermata Therapeutics, Inc. (Nasdaq: DRMA) climbed 60% following the announcement of successful Phase 3 trial results for their acne treatment, XYNGARI, ...

Investorideas.com ( a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading ...